# Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects

> **NCT06653101** · NA · COMPLETED · sponsor: **Wecare Probiotics Co., Ltd.** · enrollment: 110 (actual)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06653101
- **Lead sponsor:** Wecare Probiotics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-20
- **Primary completion:** 2024-12-05
- **Final completion:** 2025-03-20
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06653101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06653101, "Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06653101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*